The Problem With the FDA’s Quick-Approval Process for Drugs

(Bloomberg Businessweek) -- One in 10 babies in the U.S. is born premature, with elevated rates of disability and death. For almost a decade, a drug called Makena has been used to reduce the risk o...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.